New data show that AI could enhance imaging-based screening for pancreatic cancer; however, its evaluation must be rigorous and adhere to the same standards used for conventional screening.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Convolutional neural network-based magnetic resonance image differentiation of filum terminale ependymomas from schwannomas
BMC Cancer Open Access 19 March 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Han, R. et al. Preprint at medRxiv https://doi.org/10.1101/2023.09.12.23295381 (2023).
Cao, K. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02640-w (2023).
Kleeff, J. et al. Nat. Rev. Dis. Primers 2, 16022 (2016).
Lång, K. et al. Lancet Oncol. 24, 936–944 (2023).
Ueda, D. et al. Lancet Digital Health 5, e525–e533 (2023).
Zhou, Y. et al. Nature 622, 156–163 (2023).
Tadesse, G. F., Tegaw, E. M. & Abdisa, E. K. J. Ultrasound 26, 355–367 (2023).
Hon, H. J., Chong, P. P., Choo, H. L. & Khine, P. P. Asian Pac. J. Cancer Prev. 24, 2207–2215 (2023).
Zhou, Y., Shi, Y., Lu, W. & Wan, F. Front Psychol. 13, 866124 (2022).
Bretthauer, M. et al. JAMA Intern. Med. https://doi.org/10.1001/jamainternmed.2023.3798 (2023).
Placido, D. et al. Nat. Med. 29, 1113–1122 (2023).
Kurian, S. J. et al. Mayo Clinic Proc. 95, 2370–2381 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no known competing financial or non-financial interests.
Rights and permissions
About this article
Cite this article
Kleeff, J., Ronellenfitsch, U. AI and imaging-based cancer screening: getting ready for prime time. Nat Med 29, 3002–3003 (2023). https://doi.org/10.1038/s41591-023-02630-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02630-y